Glioblastoma multiforme: emerging treatments and stratification markers beyond new drugs.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  British Journal of Radiology

• Publication date

  2015-08-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1259/bjr.20150354PMID 26159214PMCID PMC4743581
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Toward a cancer-specific diet.

  2016cited by this paper
• Perfusion MRI Derived Indices of Microvascular Shunting and Flow Control Correlate with Tumor Grade and Outcome in Patients with Cerebral Glioma

  2015cited by this paper
• Diffusion Tensor Imaging in brain tumors: A study on gliomas and metastases.

  2015cited by this paper
• Radiation therapy of glioblastoma.

  2015cited by this paper
• Metabolic therapy: a new paradigm for managing malignant brain cancer.

  2015cited by this paper
• A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study.

  2015cited by this paper
• Dynamic Contrast‐Enhanced Perfusion MRI and Diffusion‐Weighted Imaging in Grading of Gliomas

  2015cited by this paper
• Improving external beam radiotherapy by combination with internal irradiation.

  2015cited by this paper
• Pitfalls in the Neuroimaging of Glioblastoma in the Era of Antiangiogenic and Immuno/Targeted Therapy – Detecting Illusive Disease, Defining Response

  2015cited by this paper
• Radioimmunotherapy with α-particle-emitting radionuclides.

  2014cited by this paper
• Post-Treatment Imaging Changes in Primary Brain Tumors

  2014cited by this paper
• Rindopepimut: a promising immunotherapeutic for the treatment of glioblastoma multiforme.

  2014cited by this paper
• ERGO: A pilot study of ketogenic diet in recurrent glioblastoma

  2014cited by this paper
• Prognostic and Predictive Biomarkers in Adult and Pediatric Gliomas: Toward Personalized Treatment

  2014cited by this paper
• Volumetric spectroscopic imaging of glioblastoma multiforme radiation treatment volumes.

  2014cited by this paper
• 3-Dimensional magnetic resonance spectroscopic imaging at 3 Tesla for early response assessment of glioblastoma patients during external beam radiation therapy.

  2014cited by this paper
• Neuroimaging of therapy-associated brain tissue abnormalities.

  2014cited by this paper
• Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma.

  2014cited by this paper
• Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery.

  2014cited by this paper
• Glioblastoma recurrence patterns after radiation therapy with regard to the subventricular zone.

  2014cited by this paper
• Evaluation of the lactate-to-N-acetyl-aspartate ratio defined with magnetic resonance spectroscopic imaging before radiation therapy as a new predictive marker of the site of relapse in patients with glioblastoma multiforme.

  2014cited by this paper
• Relative biological effectiveness of the 60-MeV therapeutic proton beam at the Institute of Nuclear Physics (IFJ PAN) in Kraków, Poland

  2014cited by this paper
• [11C]-Methionine Positron Emission Tomography in the Postoperative Imaging and Followup of Patients with Primary and Recurrent Gliomas

  2014cited by this paper
• Radiotherapy of high-grade gliomas: current standards and new concepts, innovations in imaging and radiotherapy, and new therapeutic approaches

  2014cited by this paper
• Dendritic Cell-Based Vaccine for the Treatment of Malignant Glioma: A Systematic Review

  2014cited by this paper
• Applications of positron emission tomography in neuro-oncology: a clinical approach.

  2014cited by this paper
• Advanced magnetic resonance imaging of the physical processes in human glioblastoma.

  2014cited by this paper
• Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme

  2014cited by this paper
• Radiolabeled anti-EGFR-antibody improves local tumor control after external beam radiotherapy and offers theragnostic potential.

  2014cited by this paper
• Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial.

  2014cited by this paper
• The role of targeted therapies in the management of progressive glioblastoma

  2014cited by this paper
• Emerging therapies for glioblastoma.

  2014cited by this paper
• Proton therapy for the treatment of children with CNS malignancies.

  2014cited by this paper
• A randomized trial of bevacizumab for newly diagnosed glioblastoma.

  2014cited by this paper
• The role of neuropathology in the management of progressive glioblastoma

  2014cited by this paper
• Patterns of failure for glioblastoma multiforme following limited-margin radiation and concurrent temozolomide

  2014cited by this paper
• Multimodal magnetic resonance imaging evaluation of primary brain tumors.

  2014cited by this paper
• Relative biological effectiveness variation along monoenergetic and modulated Bragg peaks of a 62-MeV therapeutic proton beam: a preclinical assessment.

  2014cited by this paper
• 1p/19q testing has no significance in the workup of glioblastomas

  2013cited by this paper
• Increased subventricular zone radiation dose correlates with survival in glioblastoma patients after gross total resection.

  2013cited by this paper
• Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.

  2013cited by this paper
• Emerging methods for disease monitoring in malignant gliomas.

  2013cited by this paper
• Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma.

  2013cited by this paper
• Comparison of intraoperative fluorescence and MRI image guided neuronavigation in malignant brain tumours, a prospective controlled study.

  2013cited by this paper
• Illuminating radiogenomic characteristics of glioblastoma multiforme through integration of MR imaging, messenger RNA expression, and DNA copy number variation.

  2013cited by this paper
• Variations in the RBE for Cell Killing Along the Depth-Dose Profile of a Modulated Proton Therapy Beam

  2013cited by this paper
• Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial.

  2013cited by this paper
• Reirradiation for recurrent malignant brain tumor with radiotherapy or proton beam therapy

  2013cited by this paper
• Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial.

  2013cited by this paper
• Comparison of carbon ion radiotherapy to photon radiation alone or in combination with temozolomide in patients with high-grade gliomas: explorative hypothesis-generating retrospective analysis.

  2013cited by this paper
• Clinical controversies: proton radiation therapy for brain and skull base tumors.

  2013cited by this paper
• Can MRI-derived factors predict the survival in glioblastoma patients treated with postoperative chemoradiation therapy?

  2013cited by this paper
• Randomized trial of chemoradiotherapy and adjuvant chemotherapy with nimustine (ACNU) versus nimustine plus procarbazine for newly diagnosed anaplastic astrocytoma and glioblastoma (JCOG0305)

  2013cited by this paper
• Restricted Calorie Ketogenic Diet for the Treatment of Glioblastoma Multiforme

  2013cited by this paper
• Intraoperative tissue fluorescence using 5-aminolevolinic acid (5-ALA) is more sensitive than contrast MRI or amino acid positron emission tomography (18F-FET PET) in glioblastoma surgery

  2012cited by this paper
• De novo engineering of a human cystathionine-γ-lyase for systemic (L)-Methionine depletion cancer therapy.

  2012cited by this paper
• The Definition of Primary and Secondary Glioblastoma

  2012cited by this paper
• Advanced neuroimaging techniques in the management of glioblastoma multiforme.

  2012cited by this paper
• Glioblastoma: therapeutic challenges, what lies ahead.

  2012cited by this paper
• Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial.

  2012cited by this paper
• The potential origin of glioblastoma initiating cells.

  2012cited by this paper
• Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial.

  2012cited by this paper
• Treatment-related change versus tumor recurrence in high-grade gliomas: a diagnostic conundrum--use of dynamic susceptibility contrast-enhanced (DSC) perfusion MRI.

  2012cited by this paper
• Impact of [11C]methionine positron emission tomography for target definition of glioblastoma multiforme in radiation therapy planning.

  2012cited by this paper
• Targeting methionine auxotrophy in cancer: discovery & exploration

  2012cited by this paper
• Effects of a ketogenic diet on the quality of life in 16 patients with advanced cancer: A pilot trial

  2011cited by this paper
• Radiotherapy followed by adjuvant temozolomide with or without neoadjuvant ACNU-CDDP chemotherapy in newly diagnosed glioblastomas: a prospective randomized controlled multicenter phase III trial

  2011cited by this paper
• External beam radiotherapy followed by 90Y ibritumomab tiuxetan in relapsed or refractory bulky follicular lymphoma.

  2011cited by this paper
• Patterns of failure for glioblastoma multiforme following concurrent radiation and temozolomide

  2011cited by this paper
• Clinical applications of imaging biomarkers. Part 2. The neurosurgeon's perspective.

  2011cited by this paper
• Glioblastoma: Patterns of Recurrence and Efficacy of Salvage Treatments

  2011cited by this paper
• Intraoperative MRI-guided resection of glioblastoma multiforme: a systematic review.

  2011cited by this paper
• Phase I/II trial of hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme.

  2010cited by this paper
• Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide.

  2010cited by this paper
• Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma.

  2010cited by this paper
• Radiographic patterns of relapse in glioblastoma

  2010cited by this paper
• Metabolic management of glioblastoma multiforme using standard therapy together with a restricted ketogenic diet: Case Report

  2010cited by this paper
• A Phase II study of anti-epidermal growth factor receptor radioimmunotherapy in the treatment of glioblastoma multiforme.

  2010cited by this paper
• Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: The CINDERELLA trial

  2010cited by this paper
• Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.

  2010cited by this paper
• Acute traumatic death of a 17th century general based on examination of mummified remains found in Korea.

  2009cited by this paper
• Association of 11C-methionine PET uptake with site of failure after concurrent temozolomide and radiation for primary glioblastoma multiforme.

  2009cited by this paper
• Glioma surgery using a multimodal navigation system with integrated metabolic images.

  2009cited by this paper
• Phase II trial of the association of a methionine-free diet with cystemustine therapy in melanoma and glioma.

  2009cited by this paper
• Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma.

  2009cited by this paper
• Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

  2009cited by this paper
• IDH1 and IDH2 mutations in gliomas.

  2009cited by this paper
• l-[METHYL-(11)C] methionine positron emission tomography for target delineation in malignant gliomas: impact on results of carbon ion radiotherapy.

  2008cited by this paper
• Phase I single-dose study of intracavitary-administered Nimotuzumab labeled with 188-Re in adult recurrent high-grade glioma

  2008cited by this paper
• Proton magnetic resonance spectroscopic imaging in newly diagnosed glioblastoma: predictive value for the site of postradiotherapy relapse in a prospective longitudinal study.

  2008cited by this paper
• Analysis of the IDH1 codon 132 mutation in brain tumors

  2008cited by this paper
• A pilot study: 131I-antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost.

  2008cited by this paper
• Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.

  2008cited by this paper
• Proton therapy in clinical practice: current clinical evidence.

  2007cited by this paper
• The 2007 WHO Classification of Tumours of the Central Nervous System

  2007cited by this paper
• WHO classification of tumours of the central nervous system

  2007cited by this paper
• Clinical Experience with α-Particle–Emitting 211At: Treatment of Recurrent Brain Tumor Patients with 211At-Labeled Chimeric Antitenascin Monoclonal Antibody 81C6

  2007cited by this paper
• Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy.

  2007cited by this paper
• Patterns of recurrence analysis in newly diagnosed glioblastoma multiforme after three-dimensional conformal radiation therapy with respect to pre-radiation therapy magnetic resonance spectroscopic findings.

  2007cited by this paper
• Optimal Methionine-Free Diet Duration for Nitrourea Treatment: A Phase I Clinical Trial

  2007cited by this paper

• [177Lu]Lu-XYIMSR-01: A Novel CAIX-Targeted Radiotherapeutic for Enhanced Treatment of Malignant Glioma.

  2025cites this paper
• Updates on glioblastoma multiforme: From epidemiology to imaging and artificial intelligence

  2025cites this paper
• Does human cytomegalovirus provide a novel therapeutic target for patients with glioblastoma?

  2025cites this paper
• Efficacy of 15 nm Gold Nanoparticles for Image-Guided Gliosarcoma Radiotherapy

  2023cites this paper
• Platycodin D inhibits glioblastoma cell proliferation, migration, and invasion by regulating DEPDC1B-mediated epithelial-to-mesenchymal transition.

  2023cites this paper
• The signature of immune-subtype specific driving transcription factors suggest potential drugs for refractory glioblastoma.

  2023cites this paper
• Combined Treatment of Cancer Cells Using Allyl Palladium Complexes Bearing Purine-Based NHC Ligands and Molecules Targeting MicroRNAs miR-221-3p and miR-222-3p: Synergistic Effects on Apoptosis

  2023cites this paper
• Fast and accurate dose predictions for novel radiotherapy treatments in heterogeneous phantoms using conditional 3D-UNet generative adversarial networks.

  2022cites this paper
• Valganciclovir as Add-on to Second-Line Therapy in Patients with Recurrent Glioblastoma

  2022cites this paper
• Editorial: Brain Cancers: New Perspectives and Therapies

  2022influential citation
• Gangliosides as Biomarkers of Human Brain Diseases: Trends in Discovery and Characterization by High-Performance Mass Spectrometry

  2022cites this paper
• Immunohistochemical Detection and Prognostic Significance of p53, Epidermal Growth Factor Receptor, Murine Double Minute 2, and Isocitrate Dehydrogenase 1 in Glioblastoma Multiforme Patients of Pakistan

  2022cites this paper
• Echinacoside (ECH) suppresses proliferation, migration, and invasion of human glioblastoma cells by inhibiting Skp2-triggered epithelial-mesenchymal transition (EMT).

  2022cites this paper
• Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments

  2022cites this paper
• Synergistic Effects of A Combined Treatment of Glioblastoma U251 Cells with An Anti-miR-10b-5p Molecule and An AntiCancer Agent Based on 1-(3′,4′,5′-Trimethoxyphenyl)-2-Aryl-1H-Imidazole Scaffold

  2022cites this paper
• Treatment of Human Glioblastoma U251 Cells with Sulforaphane and a Peptide Nucleic Acid (PNA) Targeting miR-15b-5p: Synergistic Effects on Induction of Apoptosis

  2022cites this paper
• Single-cell chromatin accessibility profiling of glioblastoma identifies an invasive cancer stem cell population associated with lower survival

  2021cites this paper
• Synergistic effects of the combined treatment of U251 and T98G glioma cells with an anti-tubulin tetrahydrothieno[2,3-c]pyridine derivative and a peptide nucleic acid targeting miR-221-3p

  2021cites this paper
• The Neurogenic Compound P7C3 Regulates the Aerobic Glycolysis by Targeting Phosphoglycerate Kinase 1 in Glioma

  2021cites this paper
• The Effect of Iodine-131 Beta-particles in Combination With A-966492 and Topotecan on Radio-sensitization of Glioblastoma

  2021cites this paper
• LHPP impedes energy metabolism by inducing ubiquitin-mediated degradation of PKM2 in glioblastoma.

  2021cites this paper
• The white matter is a pro-differentiative niche for glioblastoma

  2021cites this paper
• The effect of iodine-131 beta-particles in combination with A-966492 and Topotecan on radio-sensitization of glioblastoma: An in-vitro study.

  2021cites this paper
• A New Platinum-Based Prodrug Candidate for Chemotherapy and Its Synergistic Effect With Hadrontherapy: Novel Strategy to Treat Glioblastoma

  2021influential citation
• Advanced Magnetic Resonance Imaging in Pediatric Glioblastomas

  2021cites this paper
• Combined Therapy With Avastin, a PAF Receptor Antagonist and a Lipid Mediator Inhibited Glioblastoma Tumor Growth

  2021cites this paper
• Berberine reduces temozolomide resistance by inducing autophagy via the ERK1/2 signaling pathway in glioblastoma

  2020cites this paper
• Synchrotron X-ray boost delivered by Microbeam Radiation Therapy after conventional X-ray therapy fractionated in time improves F98 glioma control.

  2020cites this paper
• Norrin mediates tumor-promoting and -suppressive effects in glioblastoma via Notch and WNT.

  2020cites this paper
• A facile and scalable in production non-viral gene engineered mesenchymal stem cells for effective suppression of temozolomide-resistant (TMZR) glioblastoma growth

  2020cites this paper
• Comparison of Panitumumab-IRDye800CW and 5-Aminolevulinic Acid to Provide Optical Contrast in a Model of Glioblastoma Multiforme

  2020cites this paper
• Toward personalized synchrotron microbeam radiation therapy

  2020cites this paper
• The white matter is a pro-differentiative microenvironment for glioblastoma

  2020cites this paper
• Mass Spectrometry for Cancer Biomarkers

  2019cites this paper
• Intracavitary radioimmunotherapy of high-grade gliomas: present status and future developments

  2019cites this paper
• The Value of Diffusion-weighted Magnetic Resonance Imaging in the Preoperative Evaluation of the Grade of Brain Gliomas

  2019cites this paper
• Targeting miR-155-5p and miR-221-3p by peptide nucleic acids induces caspase-3 activation and apoptosis in temozolomide-resistant T98G glioma cells

  2019cites this paper
• Peptide nucleic acid-based targeting of microRNAs: possible therapeutic applications for glioblastoma

  2019cites this paper
• Constitutive IRE1α signaling maintains glioblastoma cell differentiation

  2019cites this paper
• Local Therapies

  2019cites this paper
• Correlation of conventional magnetic resonance imaging features with O6-methylguanine-DNA-methyltransferase gene promoter methylation status and survival outcomes in patients with newly diagnosed glioblastoma: Single-center correlative imaging substudy from a prospective clinical trial

  2018cites this paper
• Sequencing the next generation of glioblastomas

  2018cites this paper
• NEO212: sub-cytotoxic doses capable of inhibiting glioma stem cell invasion

  2018cites this paper
• Combination Therapy with Sulfasalazine and Valproic Acid Promotes Human Glioblastoma Cell Death Through Imbalance of the Intracellular Oxidative Response

  2018cites this paper
• NEO212 Inhibits Migration and Invasion of Glioma Stem Cells

  2018cites this paper
• Characterization of an Orthotopic Rat Model of Glioblastoma Using Multiparametric Magnetic Resonance Imaging and Bioluminescence Imaging

  2018cites this paper
• Chromatin Blueprint of Glioblastoma Stem Cells Reveals Common Drug Candidates for Distinct Subtypes

  2018cites this paper
• Aberrant ganglioside composition in glioblastoma multiforme and peritumoral tissue: A mass spectrometry characterization.

  2017cites this paper
• Asociación de genes relacionados con la resistencia a radioterapia y genes implicados en la división asimétrica de células madre tumorales

  2017cites this paper
• 9 PET Imaging in Glioblastoma: Use in Clinical Practice

  2017cites this paper
• R and Bioconductor Tools for Class Discovery Analysis : Example Analysis with Glioblastoma Multiforme (GBM) Data

  2017influential citation
• Nanoparticulate Tetrac Inhibits Growth and Vascularity of Glioblastoma Xenografts

  2017cites this paper
• Photodynamic therapies of high-grade gliomas: from theory to clinical perspectives. (Thérapies photodynamiques appliquées aux gliomes de haut grade : de la théorie à la réalité clinique)

  2017cites this paper
• Functional network analysis of gene-phenotype connectivity associated with temozolomide

  2017cites this paper
• Brain Tumors: An Update on Clinical PET Research in Gliomas.

  2017cites this paper
• Microtubule actin cross-linking factor 1, a novel target in glioblastoma.

  2017cites this paper
• ASCL1 Reorganizes Chromatin to Direct Neuronal Fate and Suppress Tumorigenicity of Glioblastoma Stem Cells.

  2017cites this paper
• Association between tumor architecture derived from generalized Q-space MRI and survival in glioblastoma

  2017cites this paper
• Current Clinical Brain Tumor Imaging

  2017cites this paper
• Characterization of the distribution, retention, and efficacy of internal radiation of 188Re-lipid nanocapsules in an immunocompromised human glioblastoma model

  2016cites this paper
• High-mobility group AT-hook protein 2 expression and its prognostic significance in MGMT methylated and unmethylated glioblastoma.

  2016cites this paper
• Glioblastoma Invoking "Killer" Rabbits of the Middle Ages.

  2016cites this paper
• Improving the application of PET to radiotherapy via preclinical research: Status and potential

  2016cites this paper
• High-mobility group AT-hook protein 2

  2016cites this paper
• Towards understanding of Human Cytomegalovirus in Glioblastoma

  2016influential citation
• Neurobehavioral radiation mitigation to standard brain cancer therapy regimens by Mn(III) n‐butoxyethylpyridylporphyrin‐based redox modifier

  2016cites this paper
• Efficacy of 15 nm Gold Nanoparticles for Image-Guided Gliosarcoma Radiotherapy

  year unknowncites this paper